Delivery Order SPE2D019D0002-SPE2D325F283B

The Harvard Drug Group, L.L.C., a Native Hawaiian Organization-owned pharmaceutical distributor and subsidiary of Cardinal Health, Inc., was awarded a delivery order contract by the Defense Logistics Agency Troop Support Medical (operating under the alternate name Medical Supply Chain) on August 1, 2025. The award covers the supply of Mucus Relief DM ER 600-30 mg tablets in quantities of 20 per package, with a ceiling value of $3,305.10 under a firm fixed-price delivery order structure. The place of performance is La Vergne, Tennessee, with an ultimate completion date of August 4, 2025. This award was issued without a set-aside designation, indicating unrestricted full and open competition.

This delivery order represents a single-line item purchase within The Harvard Drug Group's larger Federal Supply Schedule contract with the Department of Veterans Affairs National Acquisition Center for pharmaceutical and medical products (65 I B category), which carries a substantial ceiling value of $420.1 million through May 31, 2030. The contract aligns with the Defense Logistics Agency Troop Support Medical's mission to provide essential pharmaceutical supplies to federal healthcare infrastructure, including military and veterans medical systems. As a critical pharmaceutical vendor with extensive distribution capabilities, The Harvard Drug Group continues to support federal agencies' medical supply chain requirements through delivery orders for over-the-counter medications and other medical consumables.